Literature DB >> 24842904

Autoactivation of the MDM2 E3 ligase by intramolecular interaction.

Qian Cheng1, Tanjing Song1, Lihong Chen1, Jiandong Chen2.   

Abstract

The RING domain ubiquitin E3 ligase MDM2 is a key regulator of p53 degradation and a mediator of signals that stabilize p53. The current understanding of the mechanisms by which MDM2 posttranslational modifications and protein binding cause p53 stabilization remains incomplete. Here we present evidence that the MDM2 central acidic region is critical for activating RING domain E3 ligase activity. A 30-amino-acid minimal region of the acidic domain binds to the RING domain through intramolecular interactions and stimulates the catalytic function of the RING domain in promoting ubiquitin release from charged E2. The minimal activation sequence is also the binding site for the ARF tumor suppressor, which inhibits ubiquitination of p53. The acidic domain-RING domain intramolecular interaction is modulated by ATM-mediated phosphorylation near the RING domain or by binding of ARF. These results suggest that MDM2 phosphorylation and association with protein regulators share a mechanism in inhibiting the E3 ligase function and stabilizing p53 and suggest that targeting the MDM2 autoactivation mechanism may be useful for therapeutic modulation of p53 levels.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24842904      PMCID: PMC4135571          DOI: 10.1128/MCB.00246-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  Proteolytic cleavage of the mdm2 oncoprotein during apoptosis.

Authors:  L Chen; V Marechal; J Moreau; A J Levine; J Chen
Journal:  J Biol Chem       Date:  1997-09-05       Impact factor: 5.157

2.  Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells.

Authors:  Yili Yang; Robert L Ludwig; Jane P Jensen; Shervon A Pierre; Maxine V Medaglia; Ilia V Davydov; Yassamin J Safiran; Pankaj Oberoi; John H Kenten; Andrew C Phillips; Allan M Weissman; Karen H Vousden
Journal:  Cancer Cell       Date:  2005-06       Impact factor: 31.743

3.  MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.

Authors:  Chuangui Wang; Alexey Ivanov; Lihong Chen; William J Fredericks; Ed Seto; Frank J Rauscher; Jiandong Chen
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

4.  Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.

Authors:  Roman Kulikov; Karen A Boehme; Christine Blattner
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

5.  Protein kinase CK1delta phosphorylates key sites in the acidic domain of murine double-minute clone 2 protein (MDM2) that regulate p53 turnover.

Authors:  Markus Winter; Diane Milne; Sylvia Dias; Roman Kulikov; Uwe Knippschild; Christine Blattner; David Meek
Journal:  Biochemistry       Date:  2004-12-28       Impact factor: 3.162

6.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.

Authors:  R Honda; H Tanaka; H Yasuda
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

Review 7.  Intrinsically unstructured proteins and their functions.

Authors:  H Jane Dyson; Peter E Wright
Journal:  Nat Rev Mol Cell Biol       Date:  2005-03       Impact factor: 94.444

8.  Regulation of p53 stability by Mdm2.

Authors:  M H Kubbutat; S N Jones; K H Vousden
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

9.  Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4.

Authors:  Jason D Grier; Shunbin Xiong; Ana C Elizondo-Fraire; John M Parant; Guillermina Lozano
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

10.  A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.

Authors:  P G Komarov; E A Komarova; R V Kondratov; K Christov-Tselkov; J S Coon; M V Chernov; A V Gudkov
Journal:  Science       Date:  1999-09-10       Impact factor: 47.728

View more
  13 in total

1.  Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.

Authors:  Naoe T Nihira; Kohei Ogura; Kouhei Shimizu; Brian J North; Jinfang Zhang; Daming Gao; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Sci Signal       Date:  2017-02-14       Impact factor: 8.192

2.  Autoinhibition of MDMX by intramolecular p53 mimicry.

Authors:  Lihong Chen; Wade Borcherds; Shaofang Wu; Andreas Becker; Ernst Schonbrunn; Gary W Daughdrill; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

3.  Interaction between p53 N terminus and core domain regulates specific and nonspecific DNA binding.

Authors:  Fan He; Wade Borcherds; Tanjing Song; Xi Wei; Mousumi Das; Lihong Chen; Gary W Daughdrill; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-15       Impact factor: 11.205

4.  Characterization of cancer-associated missense mutations in MDM2.

Authors:  Krishna M Chauhan; Gopalakrishnan Ramakrishnan; Madhusudhan Kollareddy; Luis A Martinez
Journal:  Mol Cell Oncol       Date:  2015-12-10

5.  Hyperglycemia promotes p53-Mdm2 interaction but reduces p53 ubiquitination in RINm5F cells.

Authors:  R Barzalobre-Gerónimo; Barzalobre-Gerónimo Raúl; L A Flores-López; Flores-López Luis Antonio; L A Baiza-Gutman; Baiza-Gutman Luis Arturo; M Cruz; Cruz Miguel; R García-Macedo; García-Macedo Rebeca; A Ávalos-Rodríguez; Ávalos-Rodríguez Alejandro; A Contreras-Ramos; Contreras-Ramos Alejandra; A Díaz-Flores; Díaz-Flores Margarita; C Ortega-Camarillo; Ortega-Camarillo Clara
Journal:  Mol Cell Biochem       Date:  2015-04-28       Impact factor: 3.396

6.  Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity.

Authors:  Leixiang Yang; Tanjing Song; Qian Cheng; Lihong Chen; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2019-02-04       Impact factor: 4.272

Review 7.  MDM2 oligomers: antagonizers of the guardian of the genome.

Authors:  P L Leslie; Y Zhang
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

8.  Allosteric Interactions by p53 mRNA Govern HDM2 E3 Ubiquitin Ligase Specificity under Different Conditions.

Authors:  Ixaura Medina-Medina; Paola García-Beltrán; Ignacio de la Mora-de la Mora; Jesús Oria-Hernández; Guy Millot; Robin Fahraeus; Horacio Reyes-Vivas; José G Sampedro; Vanesa Olivares-Illana
Journal:  Mol Cell Biol       Date:  2016-07-29       Impact factor: 4.272

9.  Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity.

Authors:  Koji Nomura; Marta Klejnot; Dominika Kowalczyk; Andreas K Hock; Gary J Sibbet; Karen H Vousden; Danny T Huang
Journal:  Nat Struct Mol Biol       Date:  2017-05-29       Impact factor: 15.369

10.  MDMX Recruits UbcH5c to Facilitate MDM2 E3 Ligase Activity and Subsequent p53 Degradation In Vivo.

Authors:  Jing Yang; Aiwen Jin; Jing Han; Xin Chen; Junnian Zheng; Yanping Zhang
Journal:  Cancer Res       Date:  2020-12-04       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.